Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemiaMarkus Pfirrmann, Bengt Simonsson, Michele Baccarani et al.|Leukemia|2015Cited by 298
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcomeMartine E.D. Chamuleau, G.J. Ossenkoppele, Arjan A. van de Loosdrecht et al.|Haematologica|2008Cited by 99
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcomeMartine E.D. Chamuleau, G.J. Ossenkoppele, Arjan A. van de Loosdrecht et al.|Haematologica|2008Cited by 85
MHC class II molecules in tumour immunology: Prognostic marker and target for immune modulationMartine E.D. Chamuleau, Arjan A. van de Loosdrecht, G.J. Ossenkoppele|Immunobiology|2006Cited by 57
High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2Martine E.D. Chamuleau, Arjan A. van de Loosdrecht, S.M.G. Jirka et al.|Leukemia Research|2011Cited by 42